CVE-2009-4548

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in ViArt Helpdesk 3.x allow remote attackers to inject arbitrary web script or HTML via the category_id parameter to (1) products.php, (2) article.php, (3) product_details.php, or (4) reviews.php; the (5) forum_id parameter to forum.php; or the (6) search_category_id parameter to products_search.php.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 2.12% Top 20%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://secunia.com/advisories/36240 third party advisory vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/52349 vdb entry
http://osvdb.org/56882 vdb entry
http://osvdb.org/56879 vdb entry
http://osvdb.org/56880 vdb entry
http://osvdb.org/56878 vdb entry
http://osvdb.org/56877 vdb entry
http://packetstormsecurity.org/0908-exploits/viarthd-xss.txt exploit
http://osvdb.org/56881 vdb entry

Frequently Asked Questions

What is the severity of CVE-2009-4548?
CVE-2009-4548 has been scored as a medium severity vulnerability.
How to fix CVE-2009-4548?
To fix CVE-2009-4548, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2009-4548 being actively exploited in the wild?
It is possible that CVE-2009-4548 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.